1. Home
  2. GV vs VIVS Comparison

GV vs VIVS Comparison

Compare GV & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Visionary Education Technology Holdings Group Inc.

GV

Visionary Education Technology Holdings Group Inc.

HOLD

Current Price

$0.74

Market Cap

5.1M

Sector

Real Estate

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

BUY

Current Price

$1.88

Market Cap

5.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
GV
VIVS
Founded
2013
2007
Country
Canada
United States
Employees
N/A
13
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
GV
VIVS
Price
$0.74
$1.88
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
61.6K
137.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$1.42
52 Week High
$9.60
$5.30

Technical Indicators

Market Signals
Indicator
GV
VIVS
Relative Strength Index (RSI) 23.96 44.91
Support Level N/A $1.75
Resistance Level $1.59 $2.19
Average True Range (ATR) 0.10 0.17
MACD -0.03 -0.02
Stochastic Oscillator 10.00 11.11

Price Performance

Historical Comparison
GV
VIVS

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: